trial · primary record
Isoniazid
Pulmonary Tuberculosis
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 341 |
| Primary completion | 2028-01-03 |
| Primary endpoint | Difference in mean log10 (Time to positivity (TTP)) slope from longitudinal mycobacteria growth indicator tube (MGIT) liquid culture measurements over the first 6 weeks of treatment |
| Registry ID | NCT06192160 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:11.667Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06192160
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.